FidoCure®
FidoCure® is the leader in Precision Medicine for Canine Oncology.
Y CombinatorWinter 2018ActiveHealthcareHealthcare ServicesOncology
What they do
Problem
Veterinarians lack accessible precision diagnostics and targeted treatment options to effectively treat dogs with cancer based on tumor genetics.
Solution
FidoCure provides canine cancer genetic sequencing and precision-medicine targeted therapy recommendations to guide veterinary oncology treatment.
Who it's for
Veterinary oncologists and veterinary clinics treating dogs with cancer.
Founders
christina lopes
Founder
Company timeline
- YC batchWinter 2018
- StatusActive
- Team size14 people
- LocationPalo Alto, CA, USA; Remote
Similar startups
FidoCure
There are more than 90 million pet dogs in the United States. Every y…
LEAH Labs
Living therapies for pets first, and their people next
Alpha-9 Oncology
Clinical-stage radiopharma pipeline of peptide-based, best-in-class o…
Guardant Health
Guardant Health is a leading oncology company focused on conquering c…
Tmunity Therapeutics
“It’s hard to say ‘we want to cure cancer.’ We do. Sometimes it’s har…
Aktis Oncology
Miniprotein-based alpha radiopharmaceuticals for oncology